Prevention of Posttraumatic Contractures with Ketotifen (PERK)
Abstract
A 1-year no cost extension was obtained for this contract. Funding has been secured from PRORP (grant number OR160026) for a Phase III RCT (contract number W81XWH-17-01-0665). An IND application to the FDA has been classified as "clinical hold". We have executed a contract with EXOVA to perform an analysis of ketotifen for trace heavy elements, the outstanding issue leading to the "clinical hold" classification. IRB approval has been obtained at the lead institution for the Phase III RCT.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2017
- Accession Number
- AD1050526
Entities
People
- Kevin A Hildebrand